Roivant’s Anti-inflammatory Drug Shows Promise in Mid-stage Study

Roivant Sciences' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's...
Reuters Health Information

Full Story →